Academic perspectives on dietary supplements use: The need for new guidelines

Thrombosis Research

Volumn 117, Issue 1-2, 2005, Pages 185-192

  Grollman, Arthur P ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; ANTIRETROVIRUS AGENT; ARISTOLOCHIA FANGCHI EXTRACT; CITRUS AURANTIUM EXTRACT; CYCLOSPORIN; DIAZEPAM; DIETHYLENE GLYCOL; DIETHYLSTILBESTROL; DIGOXIN; EPHEDRA EXTRACT; HERBACEOUS AGENT; HORMONE; HYPERICUM PERFORATUM EXTRACT; INDOMETACIN; PC SPES; PENICILLIN G; PHENACETIN; SILDENAFIL; SULFANILAMIDE; THALIDOMIDE; THEOPHYLLINE; UNCLASSIFIED DRUG; WARFARIN;

BIRTH DEFECT; CLINICAL TRIAL; CONFERENCE PAPER; DIET SUPPLEMENTATION; DRUG FATALITY; GYNECOMASTIA; HERBAL MEDICINE; HUMAN; KIDNEY FAILURE; NEPHROTOXICITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; SIDE EFFECT; UNITED STATES;

DIETARY SUPPLEMENTS; DRUG EVALUATION, PRECLINICAL; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PRODUCT SURVEILLANCE, POSTMARKETING; RESEARCH; UNITED STATES;

EID: 27744556422     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.07.011     Document Type: Conference Paper

References (41)

1. American Society of Health-System Pharmacists ASHP statement on the use of dietary supplements AM J Health-Sys Pharm 61 2004 1707 1711
2. M. Bliss William Osler: a life in medicine 1999 Oxford University Press Oxford
3. A.K. Shapiro, and E. Shapiro The powerful placebo. From ancient priest to modern physician 1997 Johns Hopkins University Press Baltimore
4. J.H. Young American health quackery 1992 Princeton University Press Princeton, NJ
5. P.J. Hilts Protecting America's health. The FDA, business, and one hundred years of regulation 2003 Alfred A. Knopf New York
6. M. Silverman, and P.R. Lee Pills, profits, and politics 1974 University of California Los Angeles
7. D.M. Marcus, and A.P. Grollman Botanical medicines-the need for new regulations N Engl J Med 347 2002 2073 2076
8. Cranston, JW. This volume session VIII: dialogue with Patient Care Organizations.
9. Dangerous Supplements Consum Rep 2004 (May) 12 18
10. C.D. DeAngelis, and P.B. Fontanarosa Drugs alias dietary supplements JAMA 2003 1519 1520
11. Institute of Medicine of the National Academies Complementary and alternative medicine (CAM) in the United States 2005 National Academies Press
12. S. Foster, and V.E. Tyler Tyler's honest herbal. A sensible guide to the use of herbs and related remedies 4th ed. 2000 Haworth Herbal Press New York
13. P.A. DeSmet Herbal remedies N Engl J Med 347 2002 2046 2056
14. R.R. Saper, S.N. Kales, J. Paquin, M.J. Burns, D.M. Eisenberg, and R.B. Davis Heavy metal content of Ayurvedic herbal medicine products JAMA 292 2004 2868 2873
15. R.J. Ko Adulterants in Asian patent medicines N Engl J Med 339 1998 847
16. E. Ernst Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review J Intern Med 252 2002 107 113
17. N.J. Gogtay, H.A. Bhatt, S.S. Dalvi, and N.A. Kshirsagar The use and safety of non-allopathic Indian medicines Drug Safety 25 2002 1005 1019
18. T. Madden Testimony before Senate subcommittee on commerce science and transportation 2003 (Oct 28)
19. PC-SPES (PDQ) National Cancer Institute http://www.cancer.gov/ cancertopics/pdq/cam/pc-spes/HealthProfessional.
20. L.S. Marks, R.S. DiPaola, P. Nelson, S. Chen, D. Heber, and A.S. Belldegrun PC-SPES: herbal formulation for prostate cancer Urology 60 2002 369
21. M. Sovak, A.L. Selignson, M. Konas, M. Hajduch, M. Dolezal, and M. Machala Herbal composition PC-SPES for management of prostate cancer: identification of active principles J Natl Cancer Inst 94 2002 1275 1281
22. Aristolochia species and aristolochic acids International agency for research on cancer monographs on the evaluation of carcinogenic risks to humans vol. 82 2002 69 128
23. L. Jackson, S. Kofman, A. Weiss, and H. Brodovsky Aristolochic acid (NSC-50413): phase I clinical study Cancer Chemother Rep 42 1964 35 37
24. U. Mengs, W. Lang, and J.-A. Poch The carcinogenic action of aristolochic acid in rats Arch Toxicol 51 1982 107 119
25. J.P. Cosyns Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date Drug Safety 26 2003 33 48
26. D. Kessler Cancer and herbs N Engl J Med 342 2000 1742 1743
27. FDA web site for aristolochic acid warning. http://www.cfsan.fda.gov/ %7Edms/addsbot.html.
28. L.S. Gold, and T.H. Sloane Aristolochic acid, an herbal carcinogen, sold on the Web after FDA alert N Eng J Med 349 2003 1576 1577
29. J.L. Nortier, M.-C. Muniz Martinex, H.H. Schemiser, V.M. Artlt, C.A. Bieler, and M. Petein Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi) N Engl J Med 342 2000 1686 1692
30. E. Mills, V.M. Montori, P. Wu, K. Gallicano, M. Clarke, and G. Guvatt Interaction of St Johns wort with conventional drugs: systematic review of clinical trials Brit Med J 329 2004 27 30
31. D.W. Kaufman, J.P. Kelly, L. Rosenberg, T.E. Anderson, and A.A. Mitchell Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey JAMA 287 3 2002 337 344
32. Vardi N. Poison pills. London: Forbes.
33. Shekelle P, Hardy ML, Morton, SC, Maglione M, Suttorp M, Roth E, et al. Ephedra and ephedrine for weight loss and athletic performance enhancement: clinical efficacy and side effects. Evidence Report/Technology Assessment No. 76. 2003.
34. A.P. Grollman Regulation of dietary drugs is long overdue N Y Times 2003 (Feb. 23)
35. A. Fugh-Berman, and A. Myers Citrus arantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research Exp Biol Med (Maywood) 229 8 2004 698 704
36. S. Okie What ails the FDA? N Engl J Med 352 2005 1063 1066
37. Looking back on the millennium in medicine N Engl J Med 342 2000 42 49
38. H.A. Guess A. Kleinman J.W. Kusek L.W. Engel The science of the placebo. Toward an interdisciplinary research agenda 2002 BMJ Books London
39. H.S. Mayberg, J.A. Silva, S.K. Brannan, J.L. Tekell, R.K. Mahurin, and S. McGinniss The functional neuroanatomy of the placebo effect Am J Psychiatry 159 5 2002 728 737
40. NCCAM strategic plan. http://nccam.nih.gov/about/plans/2005/index.htm.
41. Y.-J. Surh Cancer chemoprevention with dietary phytochemicals Nat Rev Cancer 3 2003 768 780